BICO Group
BICO.STBICO.ST · Stock Price
Historical price data
Overview
BICO Group's mission is to be the first-choice lab automation partner for pharma and biotech by automating the life science lab of the future. Founded in 2016 and publicly listed, the company has rapidly scaled through strategic acquisitions to build an integrated technology platform spanning bioprinting, liquid handling, cell line development, and lab orchestration software. With over 53,600 instruments deployed and serving leading global customers, BICO aims to accelerate therapeutic discovery and development by enhancing research efficiency, data quality, and scalability.
Technology Platform
An integrated ecosystem of life science automation technologies combining bioprinting, liquid handling robotics, cell line development, single-cell analysis, and lab orchestration software to automate and digitize research workflows.
Funding History
6Opportunities
Risk Factors
Competitive Landscape
BICO competes with large diversified players (Thermo Fisher, Danaher) in automation and niche specialists in bioprinting and liquid handling. Its differentiated strategy is offering a connected ecosystem of best-in-class brands, challenging both integrators and point-solution providers.
Company Timeline
Founded in Stockholm, Sweden
Series A: $10.0M
Series B: $15.0M
Initial Public Offering